Deserving Health International Corp.

Deserving Health International Corp.

August 01, 2014 16:53 ET

Deserving Health Announces Effective Date for Share Consolidation and License Agreement With Pleomorphic Laboratories Corporation

Share Consolidation

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 1, 2014) - Deserving Health International Corp. (the "Company") announces that it is proceeding with a share consolidation, on the basis of five (5) old shares for one (1) new share (the "Consolidation"), as was approved by the directors of the Company on August 4, 2014. As a result of the Consolidation, the 1,500,003 common shares which are currently issued and outstanding will be reduced to 300,000 common shares. Each fractional common share equal to or greater than 0.5 common shares will be rounded up to the nearest whole common share and each fractional common share less than 0.5 common shares will be rounded down to the nearest whole common share.

The effective date for the Consolidation will be August 8, 2014.

Letters of transmittal describing the process by which shareholders may obtain new share certificates representing their consolidated common shares will be mailed to registered shareholders. Shareholders who hold their shares through a broker or other intermediary and do not have shares registered in their own name will not be required to complete a letter of transmittal.

License Agreement with Pleomorphic Laboratories Corporation ("Pleomorphic")

The Company is pleased to announce that it has entered into a multi-year license agreement with Pleomorphic for certain intellectual property legally and beneficially owned by Pleomorphic, effective July 29, 2014 (the "License Agreement"). The licensed intellectual property relates to natural skincare and homeopathic products. Pursuant to the License Agreement, the Company is required to issue to Pleomorphic up to 13,000,000 common shares in the capital of the Company over a three year period.

Deserving Health International Corp. is a reporting issuer in the provinces of British Columbia and Alberta.

DESERVING HEALTH INTERNATIONAL CORP.

Simon Cheng, Director

Certain statements contained in this release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Contact Information

  • 300 - 1055 West Hastings Street
    Vancouver, British Columbia
    V6E 2E9
    604.689.0618
    604.689.0628 (FAX)